X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (448) 448
roxithromycin (413) 413
pharmacology & pharmacy (337) 337
roxithromycin - pharmacology (312) 312
anti-bacterial agents - pharmacology (309) 309
male (219) 219
erythromycin (199) 199
animals (192) 192
microbiology (182) 182
female (174) 174
azithromycin (152) 152
clarithromycin (136) 136
erythromycin - pharmacology (131) 131
adult (130) 130
macrolides (124) 124
index medicus (106) 106
microbial sensitivity tests (102) 102
roxithromycin - therapeutic use (102) 102
anti-bacterial agents - therapeutic use (95) 95
infectious diseases (95) 95
antibiotics (89) 89
mice (87) 87
clarithromycin - pharmacology (86) 86
middle aged (85) 85
cells, cultured (80) 80
macrolide antibiotics (71) 71
erythromycin - analogs & derivatives (67) 67
anti-bacterial agents - pharmacokinetics (66) 66
in-vitro (65) 65
azithromycin - pharmacology (63) 63
roxithromycin - administration & dosage (63) 63
research article (62) 62
roxithromycin - pharmacokinetics (62) 62
macrolide (60) 60
invitro (58) 58
dose-response relationship, drug (57) 57
aged (55) 55
adolescent (52) 52
rats (52) 52
neutrophils - drug effects (51) 51
anti-bacterial agents - administration & dosage (48) 48
immunology (40) 40
in vitro techniques (40) 40
pharmacokinetics (40) 40
drug interactions (38) 38
inflammation (38) 38
time factors (38) 38
inhibition (36) 36
anti-bacterial agents - adverse effects (35) 35
asthma (35) 35
oncology (35) 35
infection (34) 34
drug resistance, microbial (33) 33
neutrophils - metabolism (33) 33
roxithromycin - adverse effects (33) 33
susceptibility (33) 33
roxithromycin - chemistry (32) 32
administration, oral (30) 30
expression (30) 30
macrolides - pharmacology (30) 30
pharmacology/toxicology (30) 30
cell line (29) 29
erythromycin - pharmacokinetics (29) 29
ketolides (29) 29
mice, inbred balb c (29) 29
treatment outcome (29) 29
polycyclic compounds (28) 28
anti-bacterial agents - chemistry (27) 27
hydrogen-ion concentration (27) 27
medicine & public health (27) 27
cells (26) 26
child (26) 26
pharmacology (25) 25
respiratory system (25) 25
erythromycin - therapeutic use (24) 24
staphylococcus aureus - drug effects (24) 24
analysis (23) 23
bacteria (23) 23
chronic disease (23) 23
disease models, animal (23) 23
human polymorphonuclear leukocytes (23) 23
toxicology (23) 23
clarithromycin - therapeutic use (22) 22
phagocytosis - drug effects (22) 22
therapy (22) 22
efficacy (21) 21
mechanism (21) 21
roxithromycin - blood (21) 21
antimicrobial agents (20) 20
azithromycin - therapeutic use (20) 20
tissue distribution (20) 20
anti-bacterial agents - metabolism (19) 19
asthma - drug therapy (19) 19
invivo (19) 19
medicine, research & experimental (19) 19
respiratory tract infections - drug therapy (19) 19
streptococcus pneumoniae - drug effects (19) 19
anti-bacterial agents - blood (18) 18
bacteria - drug effects (18) 18
chemistry, medicinal (18) 18
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (671) 671
Japanese (68) 68
French (11) 11
Chinese (10) 10
Spanish (4) 4
Russian (3) 3
Dutch (1) 1
Hebrew (1) 1
Polish (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Clinical Pharmacology, ISSN 0031-6970, 5/2012, Volume 68, Issue 5, pp. 479 - 503
Macrolides have long been recognised to exert immunomodulary and anti-inflammatory actions. They are able to suppress the “cytokine storm” of inflammation and... 
Inflammation | Biomedicine | Antibiotics | Pharmacology/Toxicology | Immunomodulation | Macrolides | RESISTANT MYCOPLASMA-PNEUMONIAE | BRONCHIAL EPITHELIAL-CELLS | LONG-TERM AZITHROMYCIN | ACUTE BACTERIAL EXACERBATIONS | CHEMICALLY-MODIFIED TETRACYCLINE | OBSTRUCTIVE PULMONARY-DISEASE | BRONCHIOLITIS OBLITERANS SYNDROME | CYSTIC-FIBROSIS PATIENTS | PHARMACOLOGY & PHARMACY | NEUTROPHILIC AIRWAY INFLAMMATION | CLARITHROMYCIN IMMEDIATE-RELEASE | Lung Diseases, Obstructive - immunology | Macrolides - administration & dosage | Humans | Immunologic Factors - administration & dosage | Lung Diseases, Obstructive - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Cystic Fibrosis - immunology | Anti-Bacterial Agents - therapeutic use | Macrolides - adverse effects | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Macrolides - pharmacology | Anti-Bacterial Agents - adverse effects | Anti-Bacterial Agents - pharmacology | Immunologic Factors - adverse effects | Macrolides - therapeutic use | Anti-Bacterial Agents - administration & dosage | Cystic Fibrosis - drug therapy | Immunologic Factors - pharmacology | Immunologic Factors - therapeutic use | Medical colleges | Pneumonia | Lung diseases, Obstructive | Anti-inflammatory drugs | Bacterial pneumonia | Lung diseases | Cystic fibrosis | Erythromycin | Antibacterial agents | Asthma | Respiratory tract diseases | Cross infection | Diabetes | Nosocomial infections | Respiratory diseases | Pharmacology | Clarithromycin | Cytokines | Diabetes mellitus | Lung | Azithromycin | bronchiolitis obliterans | Bronchiectasis | Roxithromycin | Respiratory tract | Side effects | Reviews | Bronchitis | Chronic obstructive pulmonary disease
Journal Article
Journal of Periodontology, ISSN 0022-3492, 02/2014, Volume 85, Issue 2, pp. 327 - 334
Journal Article
Journal Article
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 01/2000, Volume 292, Issue 1, pp. 156 - 163
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 10/2011, Volume 50, Issue 10, pp. 637 - 664
The exposure-response relationship of anti-infective agents at the site of infection is currently being re-examined. Epithelial lining fluid (ELF) has been... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Iclaprim | Linezolid | Levofloxacin | Clarithromycin | Cefepime | Gentamicin | Azithromycin | Roxithromycin | Cefdinir | Moxifloxacin | Vancomycin | Teicoplanin | Ceftobiprole | Antibacterials | Amoxicillinclavulanic-acid | Cefditoren | Cefpodoxime-proxetil | Pulmonary-lavage | Meropenem | Interstitial-fluid | Piperacillintazobactam | Cefaclor | Ceftazidime | Netilmicin | Cefpirome | Dirithromycin | Telithromycin | Pharmacology | Erythromycin | Ertapenem | Modithromycin | Cethromycin | Telavancin | Ceftibuten | Tobramycin | Biapenem | Ciprofloxacin | Oritavancin | Pharmacokinetics | Tigecycline | Cefuroxime-axetil | COMMUNITY-ACQUIRED PNEUMONIA | VENTILATOR-ASSOCIATED PNEUMONIA | SEVERE NOSOCOMIAL PNEUMONIA | KETOLIDE ANTIMICROBIAL AGENT | HEALTHY ADULT SUBJECTS | PHARMACOLOGY & PHARMACY | MONTE-CARLO-SIMULATION | RESISTANT STREPTOCOCCUS-PNEUMONIAE | STEADY-STATE PLASMA | CRITICALLY-ILL PATIENTS | IN-VITRO ACTIVITY | Epithelium - metabolism | Humans | Bronchoalveolar Lavage Fluid - microbiology | Microbial Sensitivity Tests | Tissue Distribution | Models, Biological | Body Fluid Compartments - metabolism | Anti-Bacterial Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacology | Lung - metabolism | Bronchoalveolar Lavage Fluid - chemistry | Macrophages, Alveolar - metabolism | Anti-Bacterial Agents - administration & dosage | Monte Carlo Method
Journal Article
Drug and Chemical Toxicology, ISSN 0148-0545, 07/2017, Volume 40, Issue 3, pp. 326 - 332
Journal Article